TP53 and lung adenocarcinoma: Meanwhile, low expression of IGSF10 primarily promotes the progression of lung adenocarcinoma (LUAD) through cell cycle dysregulation mediated by the p53‐p21 axis, and secondarily through alterations in cell adhesion signaling pathways.